Company Projected Revenue: Catheter Precision Inc (VTAK)

Catheter Precision strictly adheres to RoHS regulations and sterility standards during instrument assembly. The company is implementing unique 3D arrhythmia mapping, which reduces surgical time. However, slow navigation adoption in clinics and corporate pressure create risks. The expected sales dynamics for Catheter Precision on the GURU.Markets chart show a trend where the 0.00 mark serves as a key metric for assessing future revenues.

Catheter Precision - VTAK Company Future Revenue (period 02/21/2024 - 10/05/2026)

Financial and market metric breakdowns for Catheter Precision Corp (VTAK)

- stock quotes and analyst forecast:

Stock Price Catheter Precision Corporation|VTAK - Average Forecast Price

- company stock exchange capitalization indicators:

Market Value Catheter Precision|VTAK - Value Adjusted for Debt and Cash

- balance sheet equity data:

Accounting Value per Share Catheter Precision|VTAK - Accounting Value of Company|Market Value to Book Value Ratio catheterprecision.com|VTAK - Total Asset Value of Company

- debt burden and liquidity indicators:

- financial results and valuation multiples details:

VTAK - Net Financial Result|Projected Future Earnings Catheter Precision|VTAK - Business Payback Period|Future Price to Earnings catheterprecision.com|VTAK - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Catheter Precision, Inc.|VTAK - Operating profit before amortization|Net earnings per share for the last 12 months Catheter Precision|VTAK - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months catheterprecision.com|VTAK - Net earnings per one share growth for the current year|Earnings growth forecast for next year Catheter Precision

- sales volume and revenue information:

VTAK - Revenue and Sales Volume|Company Projected Revenue catheterprecision.com|VTAK - P/S Multiple|Forward P/S Multiple Catheter Precision

Analysis of all company metrics:Catheter Precision Inc

Signature product of Catheter Precision Inc

This sales volume forecast reflects the status of Catheter Precision (VTAK) within the cardiac surgery navigation segment. The indicator measures actual market share resilience by analyzing the volatility of expected cash flows. A narrowing fluctuation range signals stabilizing demand, yet creates the risk of a sharp impulse upon breaking out of consolidation. For Catheter Precision (VTAK), this confirms the effectiveness of scaling its IT platform and expanding its equipment base. The stable trend indicates the strength of the business's fundamental positions.

Competitors of Catheter Precision

Company Projected Revenue Regeneron (REGN)|Company Future Sales Volume iRhythm Technologies Inc IRTC|Company Projected Revenue Lantheus Corp LNTH|Mineralys Corp (MLYS) - Company Expected Sales Volume|HTFL: Company Future Sales Volume|Company Expected Sales Volume Kestra Medical Technologies|ESPR (Esperion Therapeutics) - Company Future Sales Volume|Amarin Corporation - Company Future Revenue|AVR (anteristech.com) - Projected Sales Volume|TNYA: Company Future Revenue|Company Projected Revenue CVRx, Inc. (CVRX)|MIST (Milestone Pharmaceuticals) - Company Future Revenue|Projected Sales Volume CRDL (Cardiol Therapeutics Inc)|BEAT - Company Future Sales Volume|TENX: Company Future Sales Volume|ADGM: Company Projected Revenue|BCDA: Projected Sales Volume|ARCA Biopharma Inc (ABIO) - Projected Sales Volume|Company Projected Revenue Acasti Pharma Inc.|Company Expected Sales Volume Aerovate AVTE|Projected Sales Volume VERV|Projected Sales Volume Windtree (WINT)